BioMimir Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

BioMimir General Information

Description

Operator of a regenerative medicine company intended to design and manufacture synthetic biomimetic polymers that decrease inflammation. The company designs, develops, and commercializes biomaterial systems that are biodegradable and non-toxic hydrogels whose elastic properties are tuneable, enabling hospitals to provide patients with medicines for specific wounds and tissue repair.

Contact Information

Website
www.biomimir.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7-2650 Rue Maximilien-Chagnon
  • Sherbrooke, Quebec J1E 0M8
  • Canada
+1 (438)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 7-2650 Rue Maximilien-Chagnon
  • Sherbrooke, Quebec J1E 0M8
  • Canada
+1 (438)

BioMimir Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMimir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 06-Jun-2025 Completed Pre-Clinical Trials
6. Seed Round 05-May-2025 Completed Pre-Clinical Trials
5. Accelerator/Incubator 05-Mar-2024 Completed Startup
4. Accelerator/Incubator 01-Nov-2023 Completed Startup
3. Accelerator/Incubator 29-May-2023 Completed Startup
2. Seed Round 04-Apr-2023 $475K $475K Completed Startup
1. Accelerator/Incubator Completed Startup
To view BioMimir’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BioMimir Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a regenerative medicine company intended to design and manufacture synthetic biomimetic polymers that decrea
Drug Discovery
Sherbrooke, Canada
7 As of 2026

West Lafayette, IN
 

Zizers, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioMimir Competitors (4)

One of BioMimir’s 4 competitors is Cook Biotech, a Private Equity-Backed company based in West Lafayette, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cook Biotech Private Equity-Backed West Lafayette, IN
Integra Biosciences (Switzerland) Corporation Zizers, Switzerland
Integra LifeSciences Holdings Corporation Princeton, NJ
Human Biosciences Corporation Gaithersburg, MD
To view BioMimir’s complete competitors history, request access »

BioMimir Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

BioMimir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023394184-A1 Polymer for therapeutic applications, and precursors thereof Pending 16-Dec-2022
EP-4638535-A1 Polymer for therapeutic applications, and precursors thereof Pending 16-Dec-2022
US-20250346698-A1 Polymer for therapeutic applications, and precursors thereof Pending 16-Dec-2022
WO-2024124359-A1 Polymer for therapeutic applications, and precursors thereof Inactive 16-Dec-2022 C08F230/02

BioMimir Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMimir Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Innovate Calgary Accelerator/Incubator
Connection Silicon Valley Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
Adara Venture Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

BioMimir FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process